...
首页> 外文期刊>Journal of receptor and signal transduction research >Receptor tyrosine kinases: From biology to pathology
【24h】

Receptor tyrosine kinases: From biology to pathology

机译:受体酪氨酸激酶:从生物学到病理学

获取原文
获取原文并翻译 | 示例
           

摘要

Receptor tyrosine kinases (RTKs) are transmembrane proteins involved in the control of fundamental cellular processes in metazoans. RTKs possess a general structure that includes an extracellular domain, a transmembrane domain and a highly conserved tyrosine kinase domain. RTKs are classified according to their variable extracellular ligand-binding domain. Studies of human RTK members have yielded a wealth of information elucidating their importance. Improper functioning of these enzymes due to mutations, mainly in the kinase domain, is often manifested in various human diseases and is known to be involved in several types of cancer. Here we summarize most of human RTKs, their cognate ligands, as well as related diseases and discuss the eventual use of certain RTKs as new therapeutic targets.
机译:受体酪氨酸激酶(RTKs)是跨膜蛋白,参与控制后生动物的基本细胞过程。 RTK具有包括细胞外结构域,跨膜结构域和高度保守的酪氨酸激酶结构域的一般结构。 RTK根据其可变的细胞外配体结合域进行分类。对人类RTK成员的研究已产生了大量信息,阐明了其重要性。这些酶由于突变(主要在激酶结构域中)引起的功能不正常,通常表现在各种人类疾病中,并且已知与多种类型的癌症有关。在这里,我们总结了大多数人类RTK,它们的同源配体以及相关疾病,并讨论了最终将某些RTK用作新的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号